Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma after Neoadjuvant Therapy as a Prognostic Indicator for Survival

Neoadjuvant therapy has been increasingly used to treat patients with potentially resectable pancreatic ductal adenocarcinoma (PDAC). Although the College of American Pathologists (CAP) grading scheme for tumor response in post-therapy specimens has been used, its clinical significance has not been...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Surg Pathol
Main Authors: Lee, Sun Mi, Katz, Matthew H., Liu, Li, Sundar, Manonmani, Wang, Hua, Varadhachary, Gauri R., Wolff, Robert A., Lee, Jeffrey E., Maitra, Anirban, Fleming, Jason B., Rashid, Asif, Wang, Huamin
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5178828/
https://ncbi.nlm.nih.gov/pubmed/27631521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAS.0000000000000738
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados